These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 19275706)
1. Drug targets in infections with Ebola and Marburg viruses. Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706 [TBL] [Abstract][Full Text] [Related]
3. Development of treatment strategies to combat Ebola and Marburg viruses. Paragas J; Geisbert TW Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210 [TBL] [Abstract][Full Text] [Related]
4. Filoviruses: recent advances and future challenges. Bray M; Pilch R Expert Rev Anti Infect Ther; 2006 Dec; 4(6):917-21. PubMed ID: 17181407 [No Abstract] [Full Text] [Related]
5. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Bausch DG; Sprecher AG; Jeffs B; Boumandouki P Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927 [TBL] [Abstract][Full Text] [Related]
6. Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever. Smith LM; Hensley LE; Geisbert TW; Johnson J; Stossel A; Honko A; Yen JY; Geisbert J; Paragas J; Fritz E; Olinger G; Young HA; Rubins KH; Karp CL J Infect Dis; 2013 Jul; 208(2):310-8. PubMed ID: 23255566 [TBL] [Abstract][Full Text] [Related]
7. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor. Cheng H; Schafer A; Soloveva V; Gharaibeh D; Kenny T; Retterer C; Zamani R; Bavari S; Peet NP; Rong L Antiviral Res; 2017 Sep; 145():24-32. PubMed ID: 28645623 [TBL] [Abstract][Full Text] [Related]
8. The early clinical development of Ebola virus treatments. Bradfute SB Expert Opin Investig Drugs; 2017 Jan; 26(1):1-4. PubMed ID: 27838928 [No Abstract] [Full Text] [Related]
9. Identification of an antioxidant small-molecule with broad-spectrum antiviral activity. Panchal RG; Reid SP; Tran JP; Bergeron AA; Wells J; Kota KP; Aman J; Bavari S Antiviral Res; 2012 Jan; 93(1):23-9. PubMed ID: 22027648 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists. Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243 [TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins. Barrientos LG; Lasala F; Otero JR; Sanchez A; Delgado R J Infect Dis; 2004 Apr; 189(8):1440-3. PubMed ID: 15073681 [TBL] [Abstract][Full Text] [Related]